Nelson Advisors: UK Healthcare Policy Pivots to Continuous AI Lifecycle Surveillance

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has fully adopted 44 recommendations from the National Commission into the Regulation of AI in Healthcare, shifting from one-off pre-market approvals to continuous post-market surveillance and lifecycle oversight for AI medical software in the NHS. This regulatory overhaul addresses the evolving risks of non-deterministic AI models by mandating active, ongoing compliance throughout AI deployment.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it.